Hainan Huluwa Pharmaceutical Group Co., Ltd. 605199.SS Stock
Hainan Huluwa Pharmaceutical Group Co., Ltd. Price Chart
Hainan Huluwa Pharmaceutical Group Co., Ltd. 605199.SS Financial and Trading Overview
Contents
- Hainan Huluwa Pharmaceutical Group Co., Ltd. Price Chart
- Hainan Huluwa Pharmaceutical Group Co., Ltd. 605199.SS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Hainan Huluwa Pharmaceutical Group Co., Ltd.
- Q&A For Hainan Huluwa Pharmaceutical Group Co., Ltd. Stock
Hainan Huluwa Pharmaceutical Group Co., Ltd. stock price | 11.12 CNY |
Previous Close | 15.16 CNY |
Open | 15.28 CNY |
Bid | 15.13 CNY x N/A |
Ask | 15.15 CNY x N/A |
Day's Range | 15.1 - 15.28 CNY |
52 Week Range | 13.28 - 22.8 CNY |
Volume | 1.69M CNY |
Avg. Volume | 3.63M CNY |
Market Cap | 6.05B CNY |
Beta (5Y Monthly) | 0.630339 |
PE Ratio (TTM) | 63.041668 |
EPS (TTM) | 0.24 CNY |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | June 23, 2021 |
1y Target Est | N/A |
605199.SS Valuation Measures
Enterprise Value | 6.52B CNY |
Trailing P/E | 63.041668 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 3.68419 |
Price/Book (mrq) | 5.7419357 |
Enterprise Value/Revenue | 3.97 |
Enterprise Value/EBITDA | 41.998 |
Trading Information
Hainan Huluwa Pharmaceutical Group Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.630339 |
52-Week Change | -9.81% |
S&P500 52-Week Change | 20.43% |
52 Week High | 22.8 CNY |
52 Week Low | 13.28 CNY |
50-Day Moving Average | 16.31 CNY |
200-Day Moving Average | 16.59 CNY |
605199.SS Share Statistics
Avg. Volume (3 month) | 3.63M CNY |
Avg. Daily Volume (10-Days) | 2.38M CNY |
Shares Outstanding | 400.11M |
Float | 142.09M |
Short Ratio | N/A |
% Held by Insiders | 80.28% |
% Held by Institutions | 0.32% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 5.86% |
Operating Margin (ttm) | 6.66% |
Gross Margin | 54.49% |
EBITDA Margin | 9.45% |
Management Effectiveness
Return on Assets (ttm) | 3.37% |
Return on Equity (ttm) | 9.45% |
Income Statement
Revenue (ttm) | 1.64B CNY |
Revenue Per Share (ttm) | 4.08 CNY |
Quarterly Revenue Growth (yoy) | 32.10% |
Gross Profit (ttm) | 870.74M CNY |
EBITDA | 155.32M CNY |
Net Income Avi to Common (ttm) | 96.33M CNY |
Diluted EPS (ttm) | 0.24 |
Quarterly Earnings Growth (yoy) | 35.60% |
Balance Sheet
Total Cash (mrq) | 334.19M CNY |
Total Cash Per Share (mrq) | 0.84 CNY |
Total Debt (mrq) | 790.39M CNY |
Total Debt/Equity (mrq) | 74.87 CNY |
Current Ratio (mrq) | 1.404 |
Book Value Per Share (mrq) | 2.635 |
Cash Flow Statement
Operating Cash Flow (ttm) | 231.14M CNY |
Levered Free Cash Flow (ttm) | -302234336 CNY |
Profile of Hainan Huluwa Pharmaceutical Group Co., Ltd.
Country | China |
State | N/A |
City | Haikou |
Address | No. 8, Yaogu 4th Road |
ZIP | 570300 |
Phone | N/A |
Website | https://www.huluwayaoye.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 2083 |
Hainan Huluwa Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of drugs in the areas of Children's digestive system, respiratory system, anti-infection, anti-virus and other therapeutic in China. It offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicines. The company was founded in 2005 and is based in Haikou, China.
Q&A For Hainan Huluwa Pharmaceutical Group Co., Ltd. Stock
What is a current 605199.SS stock price?
Hainan Huluwa Pharmaceutical Group Co., Ltd. 605199.SS stock price today per share is 11.12 CNY.
How to purchase Hainan Huluwa Pharmaceutical Group Co., Ltd. stock?
You can buy 605199.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hainan Huluwa Pharmaceutical Group Co., Ltd.?
The stock symbol or ticker of Hainan Huluwa Pharmaceutical Group Co., Ltd. is 605199.SS.
Which industry does the Hainan Huluwa Pharmaceutical Group Co., Ltd. company belong to?
The Hainan Huluwa Pharmaceutical Group Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Hainan Huluwa Pharmaceutical Group Co., Ltd. have in circulation?
The max supply of Hainan Huluwa Pharmaceutical Group Co., Ltd. shares is 400.11M.
What is Hainan Huluwa Pharmaceutical Group Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Hainan Huluwa Pharmaceutical Group Co., Ltd. PE Ratio is 46.33333200 now.
What was Hainan Huluwa Pharmaceutical Group Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Hainan Huluwa Pharmaceutical Group Co., Ltd. EPS is 0.24 CNY over the trailing 12 months.
Which sector does the Hainan Huluwa Pharmaceutical Group Co., Ltd. company belong to?
The Hainan Huluwa Pharmaceutical Group Co., Ltd. sector is Healthcare.